These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38898693)

  • 1. An analysis of AURKB's prognostic and immunological roles across various cancers.
    Li J; Cheng C; Zhang J
    J Cell Mol Med; 2024 Jun; 28(12):e18475. PubMed ID: 38898693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidating the pan-oncologic landscape of S100A9: prognostic and therapeutic corollaries from an integrative bioinformatics and Mendelian randomization analysis.
    Chen Y; Wu Z; Yi X
    Sci Rep; 2024 Aug; 14(1):19071. PubMed ID: 39154046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
    Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
    Front Immunol; 2021; 12():646523. PubMed ID: 33679809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Aurora Kinase B Is Correlated with Diagnosis and Poor Prognosis in Hepatocellular Carcinoma.
    Zhang J; Ma J; Li Y; An Y; Du W; Yang Q; Huang M; Cai X
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pan-cancer analysis reveals correlation between RAB3B expression and tumor heterogeneity, immune microenvironment, and prognosis in multiple cancers.
    Liu XS; Chen YL; Chen YX; Wu RM; Tan F; Wang YL; Liu ZY; Gao Y; Pei ZJ
    Sci Rep; 2024 Apr; 14(1):9881. PubMed ID: 38688977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights Into the Prognostic Value and Immunological Role of NAAA in Pan-Cancer.
    Huang D; Shen J; Zhai L; Chen H; Fei J; Zhu X; Zhou J
    Front Immunol; 2021; 12():812713. PubMed ID: 35069601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value and immunological role of PDCD1 gene in pan-cancer.
    Miao Y; Wang J; Li Q; Quan W; Wang Y; Li C; Wu J; Mi D
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107080. PubMed ID: 33069926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Analysis of Glutamate-Rich WD Repeat-Containing Protein 1 and Its Potential Clinical Significance for Pancancer.
    Wu Y; Wu X; Li Y; Zhao W; Yue Y; Wu B; Liu J; Chen X; Shen A
    Biomed Res Int; 2021; 2021():8201377. PubMed ID: 34616846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin B1: A potential prognostic and immunological biomarker in pan-cancer.
    Chen Q; Ouyang L; Liu Q
    Biomol Biomed; 2024 Sep; 24(5):1150-1169. PubMed ID: 38581717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive pan-cancer analysis reveals prognostic implications of TMEM92 in the tumor immune microenvironment.
    Wu Z; Pan T; Li W; Zhang YH; Guo SH; Liu Y; Zhang L; Wang ZY
    Clin Transl Oncol; 2024 Oct; 26(10):2701-2717. PubMed ID: 38642258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of EphA2 in pan-cancer: A prognostic biomarker associated with cancer immunity.
    Li Y; Fei H; Xiao Z; Lu X; Zhang H; Liu M
    Clin Exp Pharmacol Physiol; 2024 Aug; 51(8):e13902. PubMed ID: 38886133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic and immunological effects of ZBTB7C across cancers: friend or foe?
    Chen X; Jiang Z; Wang Z; Jiang Z
    Aging (Albany NY); 2021 May; 13(9):12849-12864. PubMed ID: 33946045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA-binding protein RNPC1 acts as an oncogene in gastric cancer by stabilizing aurora kinase B mRNA.
    Ji CM; Zhang X; Fang W; Meng L; Wei X; Lu C
    Exp Cell Res; 2021 Sep; 406(1):112741. PubMed ID: 34302858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the Expression and Prognostic Value of MSH2 in Pan-Cancer Based on Bioinformatics.
    Qiu W; Ding K; Liao L; Ling Y; Luo X; Wang J
    Biomed Res Int; 2021; 2021():9485273. PubMed ID: 34859104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic and Immunological Roles of MMP-9 in Pan-Cancer.
    Zeng Y; Gao M; Lin D; Du G; Cai Y
    Biomed Res Int; 2022; 2022():2592962. PubMed ID: 35178444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of pan-cancer reveals potential of ASF1B as a prognostic and immunological biomarker.
    Hu X; Zhu H; Zhang X; He X; Xu X
    Cancer Med; 2021 Oct; 10(19):6897-6916. PubMed ID: 34472711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics Analysis Suggests the Combined Expression of AURKB and KIF18B Being an Important Event in the Development of Clear Cell Renal Cell Carcinoma.
    Liu Q; Zhang X; Tang H; Liu J; Fu C; Sun M; Zhao L; Wei M; Yu Z; Wang P
    Pathol Oncol Res; 2020 Jul; 26(3):1583-1594. PubMed ID: 31489573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GRAMD1A Is a Biomarker of Kidney Renal Clear Cell Carcinoma and Is Associated with Immune Infiltration in the Tumour Microenvironment.
    Liu Y; Fu S; Zhang Z; Wang S; Cheng X; Li Z; Ding Y; Sun T; Ma M
    Dis Markers; 2022; 2022():5939021. PubMed ID: 35860689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Potential Impact of HNRNPA2B1 on Human Cancers Prognosis and Immune Microenvironment.
    Huang T; Zhu G; Chen F
    J Immunol Res; 2024; 2024():5515307. PubMed ID: 39268079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.